Sign inGet started

OCLASSEN GLENN A

Insider CIK 1210529 · TSPT President and CEO, Director · VRCA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VRCA Verrica Pharmaceuticals In A Award deriv2019-06-122019-06-145,834— $05,834SEC↗
VRCA Verrica Pharmaceuticals In G Gift2019-01-282019-01-3175,000— $065,421SEC↗
VRCA Verrica Pharmaceuticals In G Gift2019-01-252019-01-31150,000— $0140,421SEC↗
VRCA Verrica Pharmaceuticals In C Conversion deriv2018-06-192018-06-19200,734— $00SEC↗
VRCA Verrica Pharmaceuticals In C Conversion2018-06-192018-06-19200,734— $0290,421SEC↗
VRCA Verrica Pharmaceuticals In A Award deriv2018-06-142018-06-1817,502— $017,502SEC↗
TSPT Transcept Pharmaceuticals D To issuer deriv2014-10-302014-10-3020,833— $00SEC↗
TSPT Transcept Pharmaceuticals D To issuer deriv2014-10-302014-10-3018,750— $00SEC↗
TSPT Transcept Pharmaceuticals D To issuer deriv2014-10-302014-10-307,500— $00SEC↗
TSPT Transcept Pharmaceuticals D To issuer deriv2014-10-302014-10-3015,000— $00SEC↗
TSPT Transcept Pharmaceuticals D To issuer deriv2014-10-302014-10-3012,916— $00SEC↗
TSPT Transcept Pharmaceuticals D To issuer deriv2014-10-302014-10-3012,666— $00SEC↗
TSPT Transcept Pharmaceuticals D To issuer deriv2014-10-302014-10-3014,233— $00SEC↗
TSPT Transcept Pharmaceuticals D To issuer deriv2014-10-302014-10-308,655— $00SEC↗
TSPT Transcept Pharmaceuticals A Award2014-10-302014-10-3010,613$21.59 $229.1K36,513SEC↗
TSPT Transcept Pharmaceuticals A Award deriv2013-07-152013-07-18225,000— $0225,000SEC↗
TSPT Transcept Pharmaceuticals A Award deriv2013-01-072013-01-08250,000— $0250,000SEC↗
TSPT Transcept Pharmaceuticals A Award deriv2012-02-012012-02-02180,000— $0180,000SEC↗